当前位置:首页 >英文主页 >中英对照 > 报告详情

艾昆纬(IQVIA):2025年全球药品使用报告:展望至2029年(英文版)(59页).pdf

上传人: 小*** 编号:1239105 2026-05-15 59页 4.72MB

下载:

1、Copyright 2025 IQVIA.All rights reserved.IQVIA is a registered trademark of IQVIA Inc.in the United States and various other countries.The Global Use of Medicines 2025:Outlook to 2029Global WebinarA u g u s t 2 7,2 0 2 52Todays panelistsHoward ChenHead of Services,MC&PI,ChinaAlan ThomasSenior Direct

2、or,Thought Leadership,JapanSarah RickwoodVP,Thought Leadership,EMEALuke Greenwalt VP,Thought Leadership and Innovation,U.S.Sydney ClarkVP,Consulting Services,Latin AmericaMark Omoto GM,Thought Leadership and Marketing,CanadaModerator:Murray AitkenExecutive Director,IQVIA InstituteResearch Highlights

3、:Michael KleinrockResearch Director,IQVIA InstituteResearch Highlights4 3Growth outlook continues to increaseGlobal medicines market:outlook to 2029Outlook for U.S.market is higherMedicine use rising in LATAM and AsiaGrowth outlook unchanged at 5-8%CAGR,reaching$2.4Tn by 2029,driven by immunology an

4、d oncology despite both slowing later in the forecast,and endocrinology,especially diabetes and obesityMedicine use in Latin America and Asia,including China,will grow faster than other regions over the next five yearsThe updated outlook for the U.S.market,using estimated net prices,is being raised

5、by 1 percentage points to 3-6%CAGR through 2029,reflecting higher recent growth and expected further increased patient use of higher value therapies Medicine use overall continues to increaseGlobal use of medicines grew by 14%over the past five years but an increase of only 4%is expected through 202

6、9,bringing annual use to 3.7 trillion defined daily doses and reflecting slowing growth across developed and developing economies.Global spending is increasingGlobal spending on medicine using list prices grew by 38%over the past five years and is forecast to increase by 35%through 20295156201254394

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **全球医药市场增长**:2025-2029年全球医药市场CAGR为5-8%,2029年规模达2.4万亿美元,免疫学、肿瘤学、糖尿病和肥胖症为主要驱动力。 2. **区域差异**:美国市场增速上调至3-6%(CAGR),拉丁美洲和亚洲(含中国)增长最快;日本和西欧人均用药量最高。 3. **创新与支出**:过去5年全球新增394种新活性物质(NAS),但低收入国家获取不足;全球医药支出(标价)过去5年增长38%,2025-2029年预计增长35%。 4. **治疗领域**:肿瘤学(2024年 spending 2520亿美元)和肥胖症(增速23-26%)增长领先,免疫学和糖尿病增速放缓。 5. **政策与趋势**:美国推动定价改革,中国加速创新药审批,日本通过《骨太方针》强化研发,欧洲聚焦生物安全和供应链。
**药市增长动力?** **创新药如何布局?** **区域市场差异?**
客服
商务合作
小程序
服务号
折叠